Curis Lifesciences Limited IPO
Curis Lifesciences Limited IPO
Curis Lifesciences Limited IPO
₹ 256000 / 2000 Shares Shares
Minimum Investment
Curis Lifesciences Limited IPO
Issues Price
₹120-128 per equity share
Curis Lifesciences Limited IPO
Open Date
07 Nov 2025
Close Date
11 Nov 2025
Lot Size
1000
Min. Investment
₹ 256000
Issue Price
₹120-128
Listing Date
14 Nov 2025
Issues Size
21,50,000 shares(aggregating up to ₹27.52 crore)
Face Value
₹10 Per Equity Share
Total Shares Offered
2000 Shares
Offered To Public
2000 Shares
Curis Lifesciences Limited IPO
Established in 2010, Curis Lifesciences Limited is a pharmaceutical company specializing in the development, manufacturing, and distribution of a diverse range of products. The company manufactures pharmaceutical products both internationally and nationally on a loan license or on a contract basis, and for own brand marketing.The company serves over 100 corporate clients on loan licenses or contract manufacturing and 2 clients for its own brand marketing in Yemen and Kenya. Curis Lifesciences specializes in the development, manufacturing, and distribution of a broad array of pharmaceutical products that include: General pharmaceutical tablets and capsules Oral liquids External preparations Sterile ophthalmic ointments The firm has a state-of-the-art manufacturing facility in Sanand, Gujarat, operating under strict quality control measures to ensure the safety and efficacy of its products.The company offers different pharmaceutical formulations and products made on a contract basis.They provide tablets, capsules, external preparations, oral liquids, and sterile ophthalmic ointments. As of June 30, 2024, the company has 93 permanent employees.
Founded In
2020
Managing Director
Dharmesh Dasharathbhai Patel
Parent Organization
Curis Lifesciences Limited IPO
Application for Curis Lifesciences Limited IPO
| Apply as | Price Range | Apply Upto |
|---|---|---|
| Individual (min) | ₹120-128 | ₹2,56,000 |
| Individual(max) | ₹120-128 | ₹2,56,000 |
| SHNI(min) | ₹120-128 | ₹3,84,000 |
| SHNI(max) | ₹120-128 | ₹8,96,000 |
| BHNI(min) | ₹120-128 | ₹10,24,000 |
Apply for all eligible candidates, Curis Lifesciences Limited IPO.
Open On12 Dec 2025
Close On16 Dec 2025
Price Range₹2061-2165
Testimonial
Genuine Review Form Statisifed Customers
Thanks to KSquare, I purchased my first car without loans. The SIP plan was perfectly calculated and aligned with my budget, making everything financially smooth and stress-free.
It’s rare to find an investing service that explains NFOs in such a relatable way. KSquare really bridges that gap. Very impressed!
KSquare gave me clarity in my mutual fund journey. I now know where my money goes and how it grows. Their dashboard is excellent.
I recommend KSquare to anyone who’s unsure about mutual funds. Their platform is supportive, beginner-friendly, and offers great fund insights to plan ahead.
KSquare offers outstanding NFO briefings that help investors understand the market fit. They truly empower clients with knowledge before any commitment.
I’m thankful to KSquare for making the NPS onboarding so smooth. Their resources are easy to understand for non-finance people.
KSquare guided me in building a strong emergency fund. I now feel safe knowing unexpected medical or financial situations won’t disturb our family. Truly reliable and dedicated service.
KSquare’s pension guidance was much needed. Their team helped me select the right NPS tier and gave detailed explanations.
KSquare’s SIP plans make long-term investing easier than ever. I set up my account in minutes and now watch my portfolio grow every month.
Investing in NFOs through KSquare has been a game changer. Their platform simplifies complex information and provides well-timed suggestions that fit my portfolio.
FAQ's
Frequenlty Asked Question
When do NFO units get credited to my account?
Units are credited within a few days after the NFO closes and the scheme is processed by the fund house.
Do NFOs offer better returns than existing funds?
Not always. While some NFOs may perform well, they lack historical data. KSquare helps evaluate the potential.
How does a SIP work with KSquare?
With KSquare, you can automate monthly investments into mutual funds, allowing your money to grow with market performance and compounding.
Are there any charges for managing NPS?
Yes, nominal charges apply for account maintenance and fund management, but they are among the lowest in the industry.
What is the role of the AMC in a New Fund Offering?
The Asset Management Company (AMC) designs and manages the NFO, ensuring strategy alignment and regulatory compliance.
What happens if I stop my SIP before maturity?
You can withdraw your invested amount anytime. However, early exits might impact your long-term growth potential.
Is SIP a good option for first-time investors?
Absolutely! SIPs are ideal for beginners due to their simplicity, flexibility, and potential for long-term wealth creation.
Can I change my fund manager in NPS via KSquare?
Yes, KSquare allows you to switch your fund manager or investment option once a year through your dashboard.
Ksquare Timeline Pvt. Ltd. is an AMFI Registered Mutual Fund Distributor having ARN No. 146262. Mutual Fund investments are subject to market risks. Please read all scheme related documents carefully before investing. This website is intended only for informational and self-help purposes and should not be considered as investment advice or return guarantee. Past performance is not indicative of future results. Terms & Conditions apply.